DE60028573D1 - Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren - Google Patents

Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren

Info

Publication number
DE60028573D1
DE60028573D1 DE60028573T DE60028573T DE60028573D1 DE 60028573 D1 DE60028573 D1 DE 60028573D1 DE 60028573 T DE60028573 T DE 60028573T DE 60028573 T DE60028573 T DE 60028573T DE 60028573 D1 DE60028573 D1 DE 60028573D1
Authority
DE
Germany
Prior art keywords
compositions
treatment
skin aging
aging protection
obtaining skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60028573T
Other languages
English (en)
Other versions
DE60028573T2 (de
Inventor
R Schiltz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kay Mary Inc
Original Assignee
Kay Mary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23405006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60028573(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kay Mary Inc filed Critical Kay Mary Inc
Application granted granted Critical
Publication of DE60028573D1 publication Critical patent/DE60028573D1/de
Publication of DE60028573T2 publication Critical patent/DE60028573T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60028573T 1999-07-20 2000-07-17 Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren Expired - Lifetime DE60028573T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US357288 1999-07-20
US09/357,288 US6495126B1 (en) 1999-07-20 1999-07-20 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
PCT/US2000/019477 WO2001005369A1 (en) 1999-07-20 2000-07-17 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation

Publications (2)

Publication Number Publication Date
DE60028573D1 true DE60028573D1 (de) 2006-07-20
DE60028573T2 DE60028573T2 (de) 2007-05-16

Family

ID=23405006

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028573T Expired - Lifetime DE60028573T2 (de) 1999-07-20 2000-07-17 Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren

Country Status (24)

Country Link
US (11) US6495126B1 (de)
EP (1) EP1200063B1 (de)
KR (1) KR100768413B1 (de)
CN (1) CN1213730C (de)
AR (1) AR024813A1 (de)
AT (1) ATE328573T1 (de)
AU (1) AU772445B2 (de)
BR (1) BR0012567B1 (de)
CA (1) CA2379682C (de)
CZ (1) CZ300239B6 (de)
DE (1) DE60028573T2 (de)
EA (2) EA005099B1 (de)
ES (1) ES2265351T3 (de)
HK (1) HK1043942B (de)
MX (1) MXPA02000754A (de)
MY (1) MY128963A (de)
NO (1) NO20020299L (de)
NZ (1) NZ516940A (de)
PE (1) PE20010279A1 (de)
PL (1) PL352986A1 (de)
TW (1) TWI261522B (de)
UA (1) UA72533C2 (de)
UY (1) UY26255A1 (de)
WO (1) WO2001005369A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
US6495126B1 (en) * 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
EP1166765A3 (de) * 2000-06-20 2002-05-02 Laboratoires Serobiologiques Verfahren zum Schutz der menschlichen Haut
ITPN20010004A1 (it) * 2001-01-24 2002-07-24 Giovanna Zuddas Prodotto cancella - rughe
US20030093297A1 (en) * 2001-11-08 2003-05-15 Schilling Kurt Matthew Method for providing feedback as to product efficacy
US20030161853A1 (en) * 2002-01-17 2003-08-28 L'oreal Methylglycinediacetic acid and deribatives thereof useful as exfoliating agents
US8420699B1 (en) 2002-06-19 2013-04-16 Irvine L. Dubow Composition and methods of treatment using deionized and ozonated solution
US7897642B1 (en) * 2002-06-19 2011-03-01 Dr. Irvine Dubow Compositions and methods for dry eye syndrome
US20040126449A1 (en) * 2002-12-30 2004-07-01 Gopa Majmudar Topical composition and methods for treatment of aged or environmentally damaged skin
FR2857266B1 (fr) * 2003-07-07 2007-09-21 Jean Noel Thorel Composition a usage dermatologique et/ou cosmetique, comprenant a titre de principe actif au moins un antioxydant lipophile
US20050063932A1 (en) * 2003-08-14 2005-03-24 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
EP1661973B1 (de) * 2003-09-05 2013-02-27 Shiseido Co., Ltd. Parfümzusammensetzung zur steuerung des temperaturempfindens
KR100552245B1 (ko) * 2003-10-24 2006-02-14 주식회사 코리아나화장품 예덕나무 추출물을 함유하는 주름 개선 화장료 조성물
US20060264505A1 (en) * 2003-11-07 2006-11-23 Stiefel Laboratories, Inc. Dermatological compositions
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
US20050106194A1 (en) * 2003-11-18 2005-05-19 Mary Kay Inc. Compositions for achieving benefits in skin using key cellular metabolic intermediates
US7025966B2 (en) 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
US20050142093A1 (en) * 2003-12-24 2005-06-30 Gregory Skover Treatment of skin with an apparatus and a benefit agent
US20050158258A1 (en) * 2004-01-21 2005-07-21 Mary Kay Inc. Methods and compositions for the treatment of skin changes associated with aging and environmental damage
CN100574745C (zh) * 2004-02-28 2009-12-30 Lg生活健康株式会社 擦洗用化妆组合物
US20050220832A1 (en) * 2004-03-25 2005-10-06 Richard Walton Gels containing metallic soaps and coupling agents
US20090257968A1 (en) * 2004-03-25 2009-10-15 Richard Walton Gels containing anionic surfactants and coupling agents
US20060165739A1 (en) * 2005-01-06 2006-07-27 Mary Kay Inc. Alcohol-free microemulsion composition
DE102005026069A1 (de) * 2005-06-07 2006-12-14 Goldschmidt Gmbh Topische kosmetische Formulierungen zur Regulierung und Verbesserung des Feuchtigkeitsgehalts der Haut
WO2007019048A2 (en) * 2005-08-02 2007-02-15 Mary Kay Inc. High ph compositions
CN103961278A (zh) 2006-01-19 2014-08-06 玫琳凯有限公司 包括卡卡杜李提取物或巴西莓提取物的组合物
JP5075345B2 (ja) * 2006-03-23 2012-11-21 花王株式会社 毛髪洗浄剤組成物
UA99101C2 (ru) 2006-05-19 2012-07-25 Мэри Кей, Инк. Композиция для местного ухода за кожей, содержащая соединения глицерина ди- и моносалицилата
ES2597104T3 (es) 2007-04-19 2017-01-13 Mary Kay, Inc. Composiciones que contienen extracto de magnolia
WO2008153725A2 (en) 2007-05-25 2008-12-18 North Carolina State University Viral nanoparticle cell-targeted delivery platform
US8133516B2 (en) * 2008-10-31 2012-03-13 Lauer Scott D Therapeutic ultrasound gel
ES2322122B1 (es) * 2009-02-10 2010-07-16 Laboratorios Starga S.L. Composicion cosmetica para el cuidado y reparacion de telangiectasias.
US8257720B2 (en) * 2009-04-20 2012-09-04 Conopco, Inc. Stabilized cationic ammonium compounds and compositions comprising the same
EA023290B1 (ru) 2009-08-28 2016-05-31 Мэри Кей Инк. Косметический способ и топическая композиция для омоложения, регенерации и упрочнения кожи во время сна
US8324255B2 (en) * 2009-09-15 2012-12-04 Conopco, Inc. Chelator stabilized cationic ammonium compounds and compositions comprising the same
MY160253A (en) 2010-01-12 2017-02-28 Pola Chem Ind Inc Prophylactic or ameliorating agent for pigmentation
US20110277796A1 (en) * 2010-05-13 2011-11-17 Russel Walters Method of cleansing skin having an impaired barrier
US20110305737A1 (en) * 2010-06-09 2011-12-15 NY Derm LLC Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology
GB201106161D0 (en) 2011-04-12 2011-05-25 Zephyros Inc Improvements in or relating to vehicle subframe reinforcement
WO2013096645A1 (en) 2011-12-20 2013-06-27 The Procter & Gamble Company Human skin sample methods and models for validating hypotheses for mechanisms driving skin pigmentation
JP5945142B2 (ja) * 2012-03-27 2016-07-05 株式会社 資生堂 しわ改善効果について化粧料を評価する方法
US20140112959A1 (en) 2012-10-18 2014-04-24 MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite Topical steroid composition and method
CA2905121C (en) 2013-03-12 2021-10-26 Mary Kay Inc. Preservative system
KR102267689B1 (ko) * 2013-03-15 2021-06-22 마리 케이 인코포레이티드 화장품 조성물들 및 이의 용도
CN105491991B (zh) * 2013-10-29 2019-07-19 玫琳凯有限公司 化妆品组合物
BR112016023571B1 (pt) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc. métodos para reduzir os sinais de envelhecimento da pele em um indivíduo, para aumentar a adipogênese da face e do corpo de um indivíduo e para aumentar a lipogênese da face e do corpo de um indivíduo
US10646430B2 (en) 2014-04-30 2020-05-12 Kimberly-Clark Worldwide, Inc. Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
BR112016022734B1 (pt) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc. método para redução do estresse oxidativo das células, método para redução da apoptose de células induzida pelo estresse oxidativo e método para redução do fotodano das células
MX2016013409A (es) 2014-04-30 2017-01-18 Kimberly Clark Co Metodos para reducir los signos de envejecimiento de la piel.
ES2736024T5 (es) * 2014-06-12 2022-07-01 Biomerieux Deutschland Gmbh Desenmascarar endotoxinas en solución
BR112018012749B1 (pt) 2015-12-31 2021-01-05 Colgate-Palmolive Company composições para higiene pessoal
WO2019089942A1 (en) * 2017-11-02 2019-05-09 Rick Coulon Formulations for use in the transdermal delivery of proteasome inhibitors
US20210212921A1 (en) * 2018-05-29 2021-07-15 Rr Health, Llc Compositions for Topical Treatment
CN113784642A (zh) * 2019-04-19 2021-12-10 株式会社资生堂 用于皮肤抗老化的方法以及装置
CN112076152A (zh) * 2020-09-23 2020-12-15 江苏地韵医疗科技有限公司 一种眼用组合物、其制备方法及用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518517A (en) * 1983-03-16 1985-05-21 Colgate-Palmolive Company Non-antimicrobial deodorant cleansing composition
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
US5380528A (en) * 1990-11-30 1995-01-10 Richardson-Vicks Inc. Silicone containing skin care compositions having improved oil control
US5643600A (en) * 1991-09-17 1997-07-01 Micro-Pak, Inc. Lipid vesicles containing avocado oil unsaponifiables
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
US5607678A (en) * 1994-08-24 1997-03-04 The Procter & Gamble Company Mild shower gel composition comprising unique thickener system which imparts improved lathering properties and modified rinse feel
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5540853A (en) * 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5653970A (en) * 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
WO1997002090A1 (en) * 1995-06-30 1997-01-23 Shiseido Company, Ltd. Emulsion composition
US6008173A (en) * 1995-11-03 1999-12-28 Colgate-Palmolive Co. Bar composition comprising petrolatum
US6086903A (en) * 1996-02-26 2000-07-11 The Proctor & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
AU727721B2 (en) * 1996-05-02 2000-12-21 Procter & Gamble Company, The Topical compositions comprising dispersed surfactant complex
ATE244553T1 (de) * 1996-05-02 2003-07-15 Procter & Gamble Topische zusammensetzung mit dispergiertem tensidkomplex
AU1530697A (en) * 1996-09-06 1998-03-26 Minnesota Mining And Manufacturing Company Antimicrobial compositions
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5902591A (en) * 1997-04-03 1999-05-11 La Prairie Sa Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid
EP0884045A1 (de) * 1997-06-06 1998-12-16 Pfizer Products Inc. Selbstbräunende Dihydroxyaceton Formulierungen mit verbesserter Stabilität und eine erhöte Abgabe erzeugend
US6153177A (en) * 1997-12-15 2000-11-28 Chesebrough-Ponds's Usa, Co., Division Of Conopco, Inc. Skin lightening composition
AU3368999A (en) 1998-03-31 1999-10-18 Mary Kay Inc. Skin lightening composition containing magnesium ascorbyl phosphate and uninontan-u34tm (extract formulation of cucumber extract and lemon extract)
US5945093A (en) * 1998-04-22 1999-08-31 Amway Corporation Conditioning shampoo
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
US6495126B1 (en) * 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
US7250174B2 (en) * 1999-12-07 2007-07-31 Schott Ag Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
US7226583B2 (en) * 2002-08-12 2007-06-05 Hair Systems, Inc. Composition containing leukocyte extract for the whitening or lightening of skin
WO2004110366A2 (en) * 2003-05-29 2004-12-23 Sun Pharmaceuticals Corporation Sunscreen composition
US7429391B2 (en) * 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
BRPI0620508A2 (pt) * 2005-11-14 2011-11-16 Tanning Res Lab Inc emulsão de água em óleo com filtro solar de alta eficiência

Also Published As

Publication number Publication date
CN1213730C (zh) 2005-08-10
US20090238783A1 (en) 2009-09-24
US8182799B2 (en) 2012-05-22
AU772445B2 (en) 2004-04-29
US20140017277A1 (en) 2014-01-16
UA72533C2 (en) 2005-03-15
US8568752B2 (en) 2013-10-29
US20070196314A1 (en) 2007-08-23
EA009006B1 (ru) 2007-10-26
NO20020299D0 (no) 2002-01-18
US10111828B2 (en) 2018-10-30
US6495126B1 (en) 2002-12-17
US9463156B2 (en) 2016-10-11
US20090197976A1 (en) 2009-08-06
DE60028573T2 (de) 2007-05-16
KR20020047093A (ko) 2002-06-21
US20130064847A1 (en) 2013-03-14
UY26255A1 (es) 2001-01-31
ATE328573T1 (de) 2006-06-15
US8758784B2 (en) 2014-06-24
US8273338B2 (en) 2012-09-25
US8562962B2 (en) 2013-10-22
WO2001005369A1 (en) 2001-01-25
HK1043942B (zh) 2006-11-17
CZ2002208A3 (cs) 2002-06-12
CA2379682A1 (en) 2001-01-25
NZ516940A (en) 2003-11-28
CN1373655A (zh) 2002-10-09
CA2379682C (en) 2012-01-24
US20140377304A1 (en) 2014-12-25
PL352986A1 (en) 2003-09-22
EA005099B1 (ru) 2004-10-28
MY128963A (en) 2007-03-30
AR024813A1 (es) 2002-10-23
US8252274B2 (en) 2012-08-28
CZ300239B6 (cs) 2009-03-25
ES2265351T3 (es) 2007-02-16
PE20010279A1 (es) 2001-03-07
BR0012567A (pt) 2002-04-16
US7175837B2 (en) 2007-02-13
US20030095940A1 (en) 2003-05-22
EP1200063B1 (de) 2006-06-07
US20170020803A1 (en) 2017-01-26
EP1200063A1 (de) 2002-05-02
NO20020299L (no) 2002-03-18
KR100768413B1 (ko) 2007-10-18
TWI261522B (en) 2006-09-11
HK1043942A1 (en) 2002-10-04
US20100080864A1 (en) 2010-04-01
US7425323B2 (en) 2008-09-16
EA200200185A1 (ru) 2002-12-26
EA200400911A1 (ru) 2005-06-30
US20130209384A1 (en) 2013-08-15
BR0012567B1 (pt) 2013-06-11
MXPA02000754A (es) 2003-07-14
AU6218300A (en) 2001-02-05

Similar Documents

Publication Publication Date Title
DE60028573D1 (de) Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren
DE69828620D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut
AU2003257937A8 (en) Methods and compositions for treatment of dermal conditions
DE69935345D1 (de) Methoden und zusammensetzungen zur prävention und behandlung der anämie
GB0612417D0 (en) Compositions and methods for topical treatment of skin infection
ATE362757T1 (de) Kombinationen eines hemmers der sterolabsorption und eines kardiovaskulären wirkstoffes zur behandlung von kardiovaskulären indikationen
WO2002080876A3 (fr) Utilisation d'un extrait d'algue phaeodactylum pour favoriser l'activite du proteasome des cellules de la peau
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60037249D1 (de) Visuell gesteuertes instrument zur behandlung der harninkontinenz bei der frau
DE60112807D1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
DE60023816D1 (de) Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen
DE60107889D1 (de) Verfahren zur Behandlung von Kautschukzusammensetzungen enthaltend Soja Fettsäure, Sonnenblumen Fettsäure und deren Mischungen
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
AU2003301240A8 (en) Skin cleanser compositions and methods of use
AU3173301A (en) Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
EP1651255A4 (de) Topische veterinärmedizinische zusammensetzungen und verfahren zur behandlung und prävention von infektionen
DE60327856D1 (de) Zusammensetzungen und verfahren zur hautbräunung
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60128427D1 (de) Verfahren und Einrichtungen zur elekrochemischen Behandlung eines Artikels
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
DE60003550D1 (de) Substituierte 3-pyridyl-4-arylpyrrole und deren einsatz in verfahren zur therapeutischen und prophylaktischen behandlung
ATE274044T1 (de) Zusammensetzungen zur behandlung von gewebe
DE50008353D1 (de) Zahnschleifkörper zur behandlung eines engstandes von zähnen
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60212349D1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines pharmazeutischen mittels zur prävention und behandlung von sexuellen störungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition